Trade TG Therapeutics, Inc. - TGTX CFD
What is TG Therapeutics, Inc. (TGTX)?
TG Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for the treatment of B-cell malignancies and autoimmune diseases. The company’s research and development efforts concentrate on targeted therapies that modulate the immune system and inhibit cancer cell growth. TG Therapeutics advances a pipeline of drug candidates that include monoclonal antibodies and small molecule inhibitors. The company collaborates with academic institutions and industry partners to support clinical development programs. Its business model involves progressing investigational therapies through clinical trials toward regulatory approval and market introduction. TG Therapeutics operates within the biotechnology and pharmaceutical sectors, addressing unmet medical needs in oncology and immunology.
TG Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by current market moves, with TG Therapeutics, Inc. trading at $33.61. The intraday range has been between $32.95 and $34.02, representing a daily change of -0.2085%.
FAQ: TG Therapeutics, Inc. (TGTX)
What is the current price of TGTX stock?
The current trading price is $33.61.
Does TGTX pay dividends?
Dividends are not paid by the company.
Does TGTX have a formal corporate presence or regional headquarters in the UAE?
TG Therapeutics, Inc. does not have an official presence in the UAE and operates through distributors.
What is TGTX best known for?
It is most famous for developing therapies for hematologic malignancies and autoimmune diseases.
What assets are typically shown together with TGTX?
Commonly shown alongside TGTX: Vanguard FTSE All World ex-US Small-Cap ETF, China Resources Land, Brighthouse Financial Inc
Latest shares articles



